237 related articles for article (PubMed ID: 22916211)
1. High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Seto WK; Wong DK; Fung J; Ip PP; Yuen JC; Hung IF; Lai CL; Yuen MF
PLoS One; 2012; 7(8):e43087. PubMed ID: 22916211
[TBL] [Abstract][Full Text] [Related]
2. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.
Seto WK; Lai CL; Ip PP; Fung J; Wong DK; Yuen JC; Hung IF; Yuen MF
PLoS One; 2012; 7(2):e32622. PubMed ID: 22389715
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
4. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hepatitis B surface antigen and e antigen in predicting liver histology in hepatitis B e antigen-positive chronic hepatitis B patients.
Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
Hepatol Int; 2014 Apr; 8(2):216-23. PubMed ID: 26202502
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.
Cheng PN; Tsai HW; Chiu YC; Ho CH; Wu IC; Chang TT
J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
[TBL] [Abstract][Full Text] [Related]
9. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.
Zeng DW; Liu YR; Dong J; Zhu YY; Li YB; Chen J; Zheng Q; Jiang JJ
Mol Med Rep; 2015 May; 11(5):3465-72. PubMed ID: 25592612
[TBL] [Abstract][Full Text] [Related]
10. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT.
Liao B; Wang Z; Lin S; Xu Y; Yi J; Xu M; Huang Z; Zhou Y; Zhang F; Hou J
PLoS One; 2013; 8(10):e78672. PubMed ID: 24205292
[TBL] [Abstract][Full Text] [Related]
11. Serum hepatitis B surface antigen correlates with fibrosis and necroinflammation: A multicentre perspective in China.
Zhang P; Du HB; Tong GD; Li XK; Sun XH; Chi XL; Xing YF; Zhou ZH; Li Q; Chen B; Wang H; Wang L; Jin H; Mao DW; Wang XB; Wu QK; Li FP; Hu XY; Lu BJ; Yang ZY; Zhang MX; Shi WB; He Q; Li Y; Jiang KP; Xue JD; Li XD; Jiang JM; Lu W; Tian GJ; Hu ZB; Guo JC; Li CZ; Deng X; Luo XL; Li FY; Zhang XW; Zheng YJ; Zhao G; Wang LC; Wu JH; Guo H; Mi YQ; Gong ZJ; Wang CB; Jiang F; Guo P; Yang XZ; Shi WQ; Yang HZ; Zhou Y; Sun NN; Jiao YT; Gao YQ; Zhou DQ; Ye YA
J Viral Hepat; 2018 Sep; 25(9):1017-1025. PubMed ID: 29624802
[TBL] [Abstract][Full Text] [Related]
12. Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.
Wang J; Ding W; Liu J; Liu Y; Yan X; Xia J; Wu W; Jia B; Chen Y; Gao D; Hong S; Wang X; Wang L; Tong X; Yin S; Zhang Z; Li J; Huang R; Wu C
JAMA Netw Open; 2022 Jun; 5(6):e2216485. PubMed ID: 35696167
[TBL] [Abstract][Full Text] [Related]
13. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.
Martinot-Peignoux M; Carvalho-Filho R; Lapalus M; Netto-Cardoso AC; Lada O; Batrla R; Krause F; Asselah T; Marcellin P
J Hepatol; 2013 Jun; 58(6):1089-95. PubMed ID: 23369792
[TBL] [Abstract][Full Text] [Related]
15. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].
Gao Y; Zou G; Ye J; Pan G; Rao J; Li F; Wei Y; Li X
Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):254-7. PubMed ID: 26133815
[TBL] [Abstract][Full Text] [Related]
19. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Diktas H; Karacaer Z; Özturk II; Cicek H
Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
